✦ LIBER ✦

Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 people with type 2 diabetes in the FIELD study

✍ Scribed by David Sullivan; Peta Forder; John Simes; Malcolm Whiting; Leonard Kritharides; Alistair Merrifield; Mark Donoghoe; Peter G. Colman; Neil Graham; Hannu Haapamäki; Anthony Keech

Book ID: 116407239
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 313 KB
Volume: 94
Category: Article
ISSN: 0168-8227
DOI: 10.1016/j.diabres.2011.07.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multiple outcomes associated with the us

Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy

✍ Giovanni Corrao; Silvana Antonietta Romio; Antonella Zambon; Luca Merlino; Emanu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 325 KB

Treatment options for type 2 diabetes in

Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes

✍ The TODAY Study Group 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Symptoms of depression but not anxiety a

Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

✍ J. Labad; J. F. Price; M. W. J. Strachan; F. G. R. Fowkes; J. Ding; I. J. Deary; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 98 KB

PP123-MON THE ASSOCIATION BETWEEN DIETAR

PP123-MON THE ASSOCIATION BETWEEN DIETARY INTAKE OF SODIUM AND CARDIOVASCULAR RISK FACTORS IN PEOPLE WITH TYPE 1 AND TYPE 2 DIABETES

✍ Petersen, K.; Clifton, P.M.; Keogh, J.B. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

A double-blind randomized study comparin

A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes

✍ P. D. Home; C. J. Bailey; J. Donaldson; H. Chen; M. W. Stewart 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Efficacy and safety of the dipeptidyl pe

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin

✍ K. Hermansen; M. Kipnes; E. Luo; D. Fanurik; H. Khatami; P. Stein; Sitagliptin S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB